Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

ImmBio Strikes China Deal with CNBG Unit for TB Vaccine

publication date: Nov 4, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
ImmunoBiology Ltd (ImmBio), a Cambridge, UK vaccine company, has joined with Sinopharm Vaccine Institute, a part of CNBG (China National Biotech Group), to co-develop T-BioVax, ImmBio’s proprietary TB vaccine. The goal of the partnership is to bring the T-BioVax vaccine through SFDA approval and market it in China initially. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners